During the past decade, Emergency County Clinical Hospital conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 8 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Emergency County Clinical Hospital" #1 sponsor was "Amgen" with 4 trials, followed by "Bayer" with 2 trials sponsored, "Crinetics Pharmaceuticals Inc." with 2 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored and "Iuliu Hatieganu University of Medicine and Pharmacy" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Emergency County Clinical Hospital" #1 collaborator was "Incyte Corporation" with 2 trials as a collaborator, "Regeneron Pharmaceuticals" with 2 trials as a collaborator and "County Clinical Emergency Hospital Cluj-Napoca" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Emergency County Clinical Hospital" are "Psoriatic Arthritis" (3 trials), "Acromegaly" (2 trials), "Retinopathy of Prematurity (ROP)" (2 trials), "Systemic Lupus Erythematosus" (2 trials) and "Ankylosing Spondyloarthritis" (1 trials). Many other conditions were trialed in "Emergency County Clinical Hospital" in a lesser frequency.

Most popular intervention types in "Emergency County Clinical Hospital" are "Drug" (13 trials), "Other" (2 trials), "Procedure" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Apremilast 20mg" (2 trials), "Apremilast 30mg" (2 trials), "Baricitinib" (2 trials) and "Eylea (Aflibercept, BAY86-5321)" (2 trials). Other intervention names were less common.

The vast majority of trials in "Emergency County Clinical Hospital" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Emergency County Clinical Hospital". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Emergency County Clinical Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Emergency County Clinical Hospital, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".